Print Issue: December 01, 2006

Genitourinary TB An Emerging Threat

SAN FRANCISCO—Genitourinary tuberculosis (GUTB) cases are on the rise in the United States and globally, but they often are difficult to diagnose, leading to a delay in dialysis that can worsen renal damage, according to a Turkish researcher.

Approvable Letter for Aranesp Extended Dosing

Amgen Inc., of Thousand Oaks, Calif., has received an approvable letter from the FDA for Aranesp (darbepoetin alfa) for de novo once-every-two-week dosing and for once-monthly maintenance dosing for non-dialysis CKD patients with anemia.

Effort to Halt Vendors of Fraudulent Diabetes Cures on Web

As part of an effort by the FDA and the Federal Trade Commission to halt deceptive online advertisements and sales of products misrepresented as diabetes cures or treatments, the agencies have sent approximately 180 letters and advisories to Internet outlets in the United States, Mexico, and Canada.

Pulling the Plug on Dialysis Patients

Pulling the Plug on Dialysis Patients

Nephrologist Jean Holley, MD, will never forget Deena and Mary (not their real names), two patients with end-stage renal disease (ESRD) she cared for 20 years ago who asked her to let them die. Deena, a widow in her 70s, had been on hemodialysis for eight years.

No Borders for Pathogens

For centuries, human beings have spread diseases long distances through their travels. Yellow fever and the mosquitoes that transmit it, for instance, are thought to have originated in Africa and been introduced to the New World by slave ships in the 1500s. The 1918 influenza pandemic illustrates how contagious diseases can spread throughout the world.

Next post in Commentary